The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Deep learning improves prediction of drug–drug and drug–food interactions
Open accessAbstract
Significance: Drug interactions, including drug–drug interactions (DDIs) and drug–food constituent interactions, can trigger unexpected pharmacological effects such as adverse drug events (ADEs). Several existing methods predict drug interactions, but require detailed, but often unavailable drug information as inputs, such as drug targets. To this end, we present a computational framework DeepDDI that accurately predicts DDI types for given drug pairs and drug–food constituent pairs using only name and structural information as inputs. We show four applications of DeepDDI to better understand drug interactions, including prediction of DDI mechanisms causing ADEs, suggestion of alternative drug members for the intended pharmacological effects without negative health effects, prediction of the effects of food constituents on interacting drugs, and prediction of bioactivities of food constituents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Gephi: An Open Source Software for Exploring and Manipulating Networks
Bastian, M., Heymann, S., & Jacomy, M. (2009) · Proceedings of the International AAAI Conference on Web and Social Media · doi:10.1609/icwsm.v3i1.13937 · Cited by 11,675
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.
Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,703
Deep learning for computational biology
Angermueller, C., Pärnamaa, T., Parts, L., & Stegle, O. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156651 · Cited by 1,473 · cited 2×
“Results For the development of DeepDDI to effectively classify the DDI types for a given drug pair, deep neural network (DNN) was employed among other machine learning approaches due to its proven outstanding performance in classification without the need of feature extraction (16, 17).”
BackgroundMethodTrends in Prescription Drug Use Among Adults in the United States From 1999-2012
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13766 · Cited by 1,219
A community-driven global reconstruction of human metabolism
Thiele, I., Swainston, N., Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., Haraldsdottir, H., Mo, M. L., Rolfsson, O., Stobbe, M. D., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2488 · Cited by 1,019 · cited 1×
“Also, to complement DeepDDI in understanding the mechanisms of action of multiple drugs, increasingly available complementary data and methods can be used, including transcriptome data under drug treatment conditions (27), and the use of drug target association-based methods (12–14), text mining-based methods (28, 29)…”
MethodMol2vec: Unsupervised Machine Learning Approach with Chemical Intuition
Jaeger, S., Fulle, S., & Turk, S. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00616 · Cited by 758
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8581 · Cited by 658
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0553-2 · Cited by 616
A wellness study of 108 individuals using personal, dense, dynamic data clouds
Price, N. D., Magis, A. T., Earls, J. C., Glusman, G., Levy, R., Lausted, C., McDonald, D. T., Kusebauch, U., Moss, C. L., Zhou, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3870 · Cited by 427
Pharmacokinetic drug-drug interaction and their implication in clinical management.
Palleria, C., Paolo, A. D., Giofrè, C., Caglioti, C., Leuzzi, G., Siniscalchi, A., Sarro, G. D., & Gallelli, L. (2013) · Europe PMC (PubMed Central) · Cited by 387
Cheng, F., & Zhao, Z. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002512 · Cited by 374
Drug—drug interaction through molecular structure similarity analysis
Vilar, S., Harpaz, R., Uriarte, E., Santana, L., Rabadan, R., & Friedman, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-000935 · Cited by 288
Similarity-based modeling in large-scale prediction of drug-drug interactions
Vilar, S., Uriarte, E., Santana, L., Lorberbaum, T., Hripcsak, G., Friedman, C., & Tatonetti, N. P. (2014) · Nature Protocols · doi:10.1038/nprot.2014.151 · Cited by 280
INDI: a computational framework for inferring drug interactions and their associated recommendations
Gottlieb, A., Stein, G. Y., Oron, Y., Ruppin, E., & Sharan, R. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.26 · Cited by 277
Neural network classification: a Bayesian interpretation
Wan, E. A. (1990) · IEEE Transactions on Neural Networks · doi:10.1109/72.80269 · Cited by 274
Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects
Zhang, P., Wang, F., Hu, J., & Sorrentino, R. (2015) · Scientific Reports · doi:10.1038/srep12339 · Cited by 242
In silico methods to address polypharmacology: current status, applications and future perspectives
Lavecchia, A., & Cerchia, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.007 · Cited by 225
Tari, L., Anwar, S., Liang, S., Cai, J., & Baral, C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq382 · Cited by 179
Huang, J., Niu, C., Green, C. D., Yang, L., Mei, H., & Han, J. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002998 · Cited by 175
Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints
Vilar, S., Uriarte, E., Santana, L., Tatonetti, N. P., & Friedman, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058321 · Cited by 137
A systems approach to traditional oriental medicine
Kim, H. U., Ryu, J. Y., Lee, J. O., & Lee, S. Y. (2015) · Nature Biotechnology · doi:10.1038/nbt.3167 · Cited by 123
Self-citationPark, K., Kim, D., Ha, S., & Lee, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140816 · Cited by 102
A Fatal Drug Interaction Between Clozapine and Fluoxetine
Ferslew, K. E., Hagardorn, A., Harlan, G., & McCormick, W. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs14363j · Cited by 80
Raja, K., Patrick, M. T., Elder, J. T., & Tsoi, L. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-03914-3 · Cited by 71
Drug Interactions of Clinical Importance An Updated Guide
Quinn, D. I., & Day, R. O. (1995) · Drug Safety · doi:10.2165/00002018-199512060-00005 · Cited by 65
Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713050114 · Cited by 40
Self-citation
Cited by
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
“…agents was recently published in the literature – the authors developed a computational platform, DeepDDI, for better understanding of drug– drug interactions and associated mechanisms and prediction of alternative drugs for intended clinical use without negative health effects [65].”
BackgroundAn Introduction to Machine Learning
Badillo, S., Banfai, B., Birzele, F., Davydov, I. I., Hutchinson, L., Kam‐Thong, T., Siebourg‐Polster, J., Steiert, B., & Zhang, J. D. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1796 · Cited by 799
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
A multimodal deep learning framework for predicting drug–drug interaction events
Deng, Y., Xu, X., Qiu, Y., Xia, J., Zhang, W., & Liu, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa501 · Cited by 453
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Metadata
- Authors
- Ryu, J. Y., Kim, H. U., & Lee, S. Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2018-04-16
- Volume
- 115
- Issue
- 18
- Pages
- E4304-E4311
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2802200505
- Cited by
- 655
- References
- 32
- FWCI
- 27.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.